A Study of GR1803 in Systemic Lupus Erythematosus (clinicaltrials.gov) - Jan 17, 2026 - P1/2 | N=44 | Recruiting | Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd.
New P1/2 trial • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
|